under-perform price
chang recommend
downgrad under-perform capital-expenditure
slowdown pt webinar et
downgrad share under-perform
ahead result evalu coverag univers
term resili disrupt
go detail webinar et
hope see
et webinar click link
rational sever downturn hospit capital-expenditure env
impact isrg procedur in-line
peer med-tech group given push-out elect
worri capital-expenditure environ look ahead
think pose risk hospit
think evalu capital-expenditure spend beyond current
shock system essenti spend
think anem demand big ticket item could
persist hospit go surviv mode
valuat risk environ think era
multipl justifi long growth sustain
come end pt equat
repres downsid caus us d/g
share under-perform
could wrong surgic robot still
early/mid phase adopt cycl hospit could see
surgic robot essenti differenti
big ticket item matur demand
could make shape recoveri
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect object
report investor consid report singl factor make invest decis
valuat methodolog base mix discount cash flow analysi rel valuat multipl
upsid risk earlier expect flex cath launch could drive system sale better
expect launch da vinci sp singl port acceler procedur growth
downsid risk monopoli premium goe away get detail competit product
slowdown hernia intern procedur growth
articl articl
time dissemin april pm et
analyst luke sergott jon bristow daniel markowitz vijay kumar primarili respons prepar research report attest
follow view opinion render research report reflect person view subject compani
issuer part research analyst compens directli relat specif recommend view
research report
